Article
Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo.
Virology - 1 Feb 2024
Bialy Dagmara, Richardson Samuel, Chrzastek Klaudia, Bhat Sushant, Polo Noemi, Freimanis Graham, Iqbal Munir, Shelton Holly
Abstract excerpt
The possible emergence of drug-resistant avian flu raises concerns over the limited effectiveness of currently approved antivirals (neuraminidase inhibitors - NAIs) in the hypothetical event of a zoonotic spillover. Our study demonstrated that the recombinant avian A(H6N1) viruses showed reduced inhibition (RI) by multiple NAI drugs following the introduction of point mutations found predominantly in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
